Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model

被引:22
作者
Liu, FJ
Mboudjeka, I
Shen, SY
Chou, THW
Wang, SX
Ross, TM
Lu, S
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccine, Worcester, MA 01605 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA
关键词
codon optimization; CM fusion; cell-mediated immune (CMI) responses; antibodies;
D O I
10.1016/j.vaccine.2003.09.054
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability to elicit Immoral and cell-mediated immune (CMI) responses from DNA immunization by combinational use of codon optimization and C3d component of complement was evaluated in this study. DNA vaccines that express either the wild type or the codon optimized gp120 gene coding for the envelope (Env) glycoprotein of human immunodeficiency virus (HIV-1) from the primary isolate JR-FL strain were compared to the same forms fused to three tandem copies of the murine C3d genes. Either codon optimization or C3d fusion alone was effective at generating early appearance, higher binding and neutralizing antibody responses. We also observed that cell-mediated immune responses against HIV Env could also be enhanced by C3d fusion. However, for both humoral and CMI responses, there were no synergistic effects when the combination of codon optimization and C3d fusion was employed. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1764 / 1772
页数:9
相关论文
共 34 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]  
André S, 1998, J VIROL, V72, P1497
[3]   The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region [J].
Barnet, SW ;
Lu, S ;
Srivastava, I ;
Cherpelis, S ;
Gettie, A ;
Blanchard, J ;
Wang, S ;
Mboudjeka, I ;
Leung, L ;
Lian, Y ;
Fong, A ;
Buckner, C ;
Ly, A ;
Hilt, S ;
Ulmer, J ;
Wild, CT ;
Mascola, JR ;
Stamatatos, L .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5526-5540
[4]   Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes [J].
Barouch, DH ;
Kunstman, J ;
Kuroda, MJ ;
Schmitz, JE ;
Santra, S ;
Peyerl, FW ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Gorgone, DA ;
Montefiori, DC ;
Lewis, MG ;
Wolinsky, SM ;
Letvin, NL .
NATURE, 2002, 415 (6869) :335-339
[5]   MATURATION OF THE IMMUNE-RESPONSE IN GERMINAL-CENTERS [J].
BEREK, C ;
BERGER, A ;
APEL, M .
CELL, 1991, 67 (06) :1121-1129
[6]   Neutralization titres and vertical HIV-1 transmission [J].
Bongertz, V ;
Costa, CI ;
Veloso, VG ;
Grinsztejn, B ;
Filho, ECJ ;
Calvet, G ;
Pilotto, JH .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (06) :642-644
[7]   Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients [J].
Calarota, S ;
Bratt, G ;
Nordlund, S ;
Hinkula, J ;
Leandersson, AC ;
Sandström, E ;
Wahren, B .
LANCET, 1998, 351 (9112) :1320-1325
[8]   Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity [J].
Cole, KS ;
Rowles, JL ;
Jagerski, BA ;
MurpheyCorb, M ;
Unangst, T ;
Clements, JE ;
Robinson, J ;
Wyand, MS ;
Desrosiers, RC ;
Montelaro, RC .
JOURNAL OF VIROLOGY, 1997, 71 (07) :5069-5079
[9]   FACILITATED DNA INOCULATION INDUCES ANTI-HIV-1 IMMUNITY IN-VIVO [J].
CONEY, L ;
WANG, B ;
UGEN, KE ;
BOYER, J ;
MCCALLUS, D ;
SRIKANTAN, V ;
AGADJANYAN, M ;
PACHUK, CJ ;
HEROLD, K ;
MERVA, M ;
GILBERT, L ;
DENG, KS ;
MOELLING, K ;
NEWMAN, M ;
WILLIAMS, WV ;
WEINER, DB .
VACCINE, 1994, 12 (16) :1545-1550
[10]   Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons [J].
Corbet, S ;
Vinner, L ;
Hougaard, DM ;
Bryder, K ;
Nielsen, HV ;
Nielsen, C ;
Fomsgaard, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (18) :1997-2008